Sulfated Glycans Recognized by S1 Monoclonal Antibody can Serve as a Diagnostic Marker for Malignant Pleural Mesothelioma
Sulfated Glycans Recognized by S1 Monoclonal Antibody can Serve as a Diagnostic Marker for Malignant Pleural Mesothelioma
复制标题
S1 单克隆抗体识别的硫酸聚糖可作为恶性胸膜间皮瘤的诊断标志物
DOI:
10.1007/s00408-022-00531-4
复制
发表时间:
2022
期刊:
影响因子:
5
通讯作者:
Motohiro Kobayashi
中科院分区:
文献类型:
--
作者:
Koki Nakashima;Yasuhiro Sakai;Hitomi Hoshino;Yukihiro Umeda;Hiroto Kawashima;Yoshitaka Sekido;Tamotsu Ishizuka;Motohiro Kobayashi
PurposeMalignant pleural mesothelioma (MPM) is a malignant neoplasm of the pleura caused by asbestos exposure. For diagnosis of MPM, immunohistochemistry using multiple markers is recommended to rule out differential diagnoses, such as pulmonary adenocarcinoma. However, the specificity of currently used markers is not fully satisfactory. We previously developed a monoclonal antibody named S1, which recognizes 6-sulfo sialyl Lewis x, an L-selectin ligand expressed on high endothelial venules. During the screening process, we discovered that this antibody stained normal pleural mesothelium. This finding prompted us to hypothesize that the epitope recognized by S1 might serve as a new diagnostic marker for MPM.MethodsTo test this hypothesis, we immunostained human MPM (n= 22) and lung adenocarcinoma (n= 25) tissues using S1 antibody.Results77.3% of MPM were S1 positive, and if limited to epithelioid type, the positivity rate was 100%, while that of lung adenocarcinoma was only 36.0%. Statistical analysis revealed a significant difference in the S1 positivity rate between each disease. Furthermore, immunohistochemistry using a series of anti-carbohydrate antibodies combined with glycosidase digestion revealed the structure of sulfated glycans expressed in MPM to be 6-sulfo sialylN-acetyllactosamine attached to core 2-branchedO-glycans.ConclusionWe propose that the S1 glycoepitope could serve as a new diagnostic marker for MPM.
登录
查看更多内容
DOI:
10.1083/jcb.107.5.1853
发表时间:
1988-11
期刊:
The Journal of cell biology
影响因子:
--
作者:
Streeter PR;Rouse BT;Butcher EC
通讯作者:
Butcher EC
影响因子:
64.8
作者:
Y. Lmai;L. Lasky;S. Rosen
通讯作者:
Y. Lmai;L. Lasky;S. Rosen
影响因子:
16.8
作者:
K. Uchimura;S. Rosen
通讯作者:
K. Uchimura;S. Rosen
DOI:
10.1200/jco.2017.76.6394
发表时间:
2018-05-01
期刊:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
影响因子:
--
作者:
Kindler HL;Ismaila N;Armato SG 3rd;Bueno R;Hesdorffer M;Jahan T;Jones CM;Miettinen M;Pass H;Rimner A;Rusch V;Sterman D;Thomas A;Hassan R
通讯作者:
Hassan R
影响因子:
7.3
作者:
小林基弘;他
通讯作者:
他